Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17350 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Brigitte Schopohl und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany. Hauptthemen laut MEDLINE: Angiotensin II, Myocytes, Cardiac, Homeostasis, Receptors, Cannabinoid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fritz Thyssen Stiftung, German Ministry of Research and Education, Deutsche Gesellschaft für Kardiologie Herz- und Kreislaufforschung.
Abstract (Originalsprache)
Background and Purpose Cannabis stimulates several G‐protein‐coupled‐receptors and causes bradycardia and hypotension upon sustained consumption. Moreover, in vitro studies suggest an interference of cannabinoid‐signalling with cardiomyocyte contractility and hypertrophy. We aimed at revealing a functional contribution of the cannabinoid‐sensitive receptor GPR55 to cardiomyocyte homeostasis and neurohumorally induced hypertrophy in vivo . Experimental Approach Gpr55 −/− and wild‐type (WT) mice were characterized after 28‐day angiotensin II (AngII; 1·μg·kg −1 min −1 ) or vehicle infusion. In isolated adult Gpr55 −/− and WT cardiomyocytes, mitochondrial function was assessed under naïve conditions, while cytosolic Ca 2+ handling was additionally determined following application of the selective GPR55 antagonist CID16020046. Key Results Gpr55 deficiency did not affect angiotensin II (AngII) mediated hypertrophic growth, yet, especially in females, it alleviated maladaptive pro‐hypertrophic and ‐inflammatory gene expression and improved inotropy and adrenergic responsiveness compared to WT. In‐depth analyses implied increased cytosolic Ca 2+ concentrations and transient amplitudes, and accelerated sarcomere contraction kinetics in Gpr55 −/− myocytes, which could be mimicked by GPR55 blockade with CID16020046 in female WT cells. Moreover, Gpr55 deficiency up‐regulated factors involved in glucose and fatty acid transport independent of the AngII challenge, accelerated basal mitochondrial respiration and reduced basal protein kinase (PK) A, G and C activity and phospholemman (PLM) phosphorylation. Conclusions and Implications Our study suggests GPR55 as crucial regulator of cardiomyocyte hypertrophy and homeostasis presumably by regulating PKC/PKA‐PLM and PKG signalling, and identifies the receptor as potential target to counteract maladaptation, adrenergic desensitization and metabolic shifts as unfavourable features of the hypertrophied heart in females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.
- Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany.
- Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.
- Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, Aachen, Germany.
- Aachen-Maastricht Institute for CardioRenal Disease (AMICARE), RWTH Aachen University, Aachen, Germany.
- Medical Clinic I, University Clinic Würzburg, Würzburg, Germany.
ORCID-Profile: Sabine Steffens, Sarah-Lena Puhl
Förderung
- Fritz Thyssen Stiftung
- German Ministry of Research and Education
- Deutsche Gesellschaft für Kardiologie Herz- und Kreislaufforschung
- Interdisciplinary Center for Clinical Research within the faculty of Medicine at the RWTH Aachen University
- Deutsche Forschungsgemeinschaft
- Friedrich-Baur funding of the Ludwig-Maximilians-University Medical Faculty
- Barth Syndrome Foundation
- Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
Zitieren
APA
Schopohl, B., Kohlhaas, M., Nickel, A. G., Schiuma, A. F., Maas, S. L., van der Vorst, E. P. C., Shia, Y. X., Maack, C., Steffens, S., & Puhl, S. L. (2025). Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice. British Journal of Pharmacology. https://doi.org/10.1111/bph.17350
Vancouver
Schopohl B, Kohlhaas M, Nickel AG, Schiuma AF, Maas SL, van der Vorst EPC, et al. Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice. British Journal of Pharmacology. 2025. doi:10.1111/bph.17350
BibTeX
@article{Schopohl2025,
author = {Schopohl, Brigitte and Kohlhaas, Michael and Nickel, Alexander G and Schiuma, Anna-Florentine and Maas, Sanne L and van der Vorst, Emiel P C and Shia, Yi Xuan and Maack, Christoph and Steffens, Sabine and Puhl, Sarah-Lena},
title = {Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17350}
}
EUVIMED